$3.93
-0.08-2%
Últ. Act.: Sep 22, 9:12 AM
Myriad Genetics Inc
MYGNNASDAQ
Myriad Genetics Earnings & Forecasts
Myriad Genetics (MYGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Myriad Genetics Guidance
Myriad Genetics (MYGN) publicó su última previsión de septiembre 16, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $770M - $790M para el período.
En comparación con la previsión anterior, Myriad Genetics mantenido redujo su previsión de ingresos desde un rango anterior de $770M - $790M.
Myriad Genetics ha emitido 29 actualizaciones de orientación entre el noviembre 1, 2022 y el septiembre 16, 2026. During this period, the company raised its outlook 7 times and lowered it 8 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.06 | $-0.09 | $-0.05 | $-0.05 |
| Actual | $-0.25 | $-0.09 | $0.04 | $0.00 |
| Surprise | -316.7% | 0.00% | +180.0% | +100.0% |
| Revenue | ||||
| Estimate | $205.9M | $202.5M | $207.6M | $205.2M |
| Actual | $190.7M | $200.4M | $209.8M | $205.7M |
| Surprise | -7.38% | -1.02% | +1.07% | +0.26% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.21 | $-0.20 | $-0.23 | $-0.24 |
| Revenue | ||||
| Consensus | $190.9M | $195.3M | — | — |